4-Bromomethcathinone (4-BMC) Revisited: The First Reported Fatal Case and Toxicological Insights
Metabolites · 21.07.2026 · 16 (7) · 507
DOI: 10.3390/metabo16070507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 21.07.2026. Verfasst von Karolina Nowak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, University of Opole, 48 Oleska Street, 45052 Opole, Poland. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
4-bromomethcathinone (4-BMC) has been present on the illicit drug market since 2011. Recent EUDA data indicate renewed availability of 4-BMC in Europe, including substantial seizures reported in 2024. Despite numerous seizures of this compound across Europe during its fourteen-year presence, no fatal intoxication involving 4-BMC has been reported so far. This paper presents the first documented fatal intoxication involving 4-BMC reported worldwide.
Methods
Quantitative determination of 4-BMC in post-mortem blood and urine was performed using the Ultra-High Performance Liquid Chromatography coupled with Triple Quadrupole Mass Spectrometry (UHPLC-QqQ-MS/MS) method, together with complementary toxicological analyses.
Results
The 4-BMC concentrations were 16,601 ng/mL in blood and over 50,000 ng/mL in urine. Both matrices also contained 3-chloromethcathinone at 1.7 ng/mL in blood and 122.2 ng/mL in urine. No other drugs, medications, or new psychoactive substances were detected apart from bromomethcathinone and chloromethcathinone metabolites.
Conclusions
This first fatal case associated with 4-BMC underscores the necessity for enhanced monitoring of this compound by both forensic and clinical toxicologists. The re-emergence of 4-BMC after more than a decade demonstrates that previously known xenobiotics may reappear and again pose a serious threat to human health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, University of Opole, 48 Oleska Street, 45052 Opole, Poland.
- Department of Forensic Medicine, Faculty of Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50345 Wroclaw, Poland.
- Department of Social Sciences and Infectious Diseases, Faculty of Medicine, Wroclaw University of Science and Technology, 27 Wybrzeze Wyspianskiego Street, 50370 Wroclaw, Poland.
- Department of Forensic Medicine, Division of Molecular Techniques, Wroclaw Medical University, 52 M. Curie-Sklodowskiej Street, 50369 Wroclaw, Poland.
- Institute of Toxicology Research, 55/61/306 M. Curie-Sklodowskiej Street, 50369 Wroclaw, Poland.
ORCID-Profile: Karolina Nowak, Paweł Szpot, Marcin Zawadzki, Agnieszka Chłopaś-Konowałek
Zitieren
APA
Nowak, K., Szpot, P., Zawadzki, M., & Chłopaś-Konowałek, A. (2026). 4-Bromomethcathinone (4-BMC) Revisited: The First Reported Fatal Case and Toxicological Insights. Metabolites, 16(7), 507. https://doi.org/10.3390/metabo16070507
Vancouver
Nowak K, Szpot P, Zawadzki M, Chłopaś-Konowałek A. 4-Bromomethcathinone (4-BMC) Revisited: The First Reported Fatal Case and Toxicological Insights. Metabolites. 2026;16(7):507. doi:10.3390/metabo16070507
BibTeX
@article{Nowak2026,
author = {Nowak, Karolina and Szpot, Paweł and Zawadzki, Marcin and Chłopaś-Konowałek, Agnieszka},
title = {4-Bromomethcathinone (4-BMC) Revisited: The First Reported Fatal Case and Toxicological Insights},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {7},
pages = {507},
doi = {10.3390/metabo16070507}
}
EUVIMED